93 related articles for article (PubMed ID: 8624793)
21. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody.
Kobayashi H; Wu C; Kim MK; Paik CH; Carrasquillo JA; Brechbiel MW
Bioconjug Chem; 1999; 10(1):103-11. PubMed ID: 9893971
[TBL] [Abstract][Full Text] [Related]
22. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Studies in a human colon cancer xenograft model.
Sharkey RM; Karacay H; Griffiths GL; Behr TM; Blumenthal RD; Mattes MJ; Hansen HJ; Goldenberg DM
Bioconjug Chem; 1997; 8(4):595-604. PubMed ID: 9258460
[TBL] [Abstract][Full Text] [Related]
23. Novel bimodal bifunctional ligands for radioimmunotherapy and targeted MRI.
Chong HS; Song HA; Ma X; Milenic DE; Brady ED; Lim S; Lee H; Baidoo K; Cheng D; Brechbiel MW
Bioconjug Chem; 2008 Jul; 19(7):1439-47. PubMed ID: 18564868
[TBL] [Abstract][Full Text] [Related]
24. Assessment of the radiochemical design of antibodies with a metabolizable linkage for target-selective radioactivity delivery.
Arano Y; Wakisaka K; Akizawa H; Ono M; Kawai K; Nakayama M; Sakahara H; Konishi J; Saji H
Bioconjug Chem; 1998; 9(4):497-506. PubMed ID: 9667952
[TBL] [Abstract][Full Text] [Related]
25. Effects of linker chemistry on the pharmacokinetics of radioimmunoconjugates.
Quadri SM; Vriesendorp HM
Q J Nucl Med; 1998 Dec; 42(4):250-61. PubMed ID: 9973840
[TBL] [Abstract][Full Text] [Related]
26. Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions.
Meares CF; McCall MJ; Reardan DT; Goodwin DA; Diamanti CI; McTigue M
Anal Biochem; 1984 Oct; 142(1):68-78. PubMed ID: 6440451
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity in rabbits and mice of an antibody-chelate conjugate: comparison of (S) and (R) macrocyclic enantiomers and an acyclic chelating agent.
Watanabe N; Goodwin DA; Meares CF; McTigue M; Chaovapong W; Ransone CM; Renn O
Cancer Res; 1994 Feb; 54(4):1049-54. PubMed ID: 8313361
[TBL] [Abstract][Full Text] [Related]
28. Large-scale synthesis of the bifunctional chelating agent 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetr aacetic acid, and the determination of its enantiomeric purity by chiral chromatography.
Renn O; Meares CF
Bioconjug Chem; 1992; 3(6):563-9. PubMed ID: 1463787
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, metal complexation and biological evaluation of a novel semi-rigid bifunctional chelating agent for 99mTc labelling.
Le Gal J; Michaud S; Gressier M; Coulais Y; Benoist E
Bioorg Med Chem; 2006 May; 14(9):2904-9. PubMed ID: 16376547
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and evaluation of a macrocyclic bifunctional chelating agent for use with bismuth radionuclides.
Garmestani K; Yao Z; Zhang M; Wong K; Park CW; Pastan I; Carrasquillo JA; Brechbiel MW
Nucl Med Biol; 2001 May; 28(4):409-18. PubMed ID: 11395314
[TBL] [Abstract][Full Text] [Related]
31. A new radiochemical method to determine the stability constants of metal chelates attached to a protein.
Subramanian KM; Wolf W
J Nucl Med; 1990 Apr; 31(4):480-8. PubMed ID: 2109050
[TBL] [Abstract][Full Text] [Related]
32. A new bifunctional chelating agent conjugated with monoclonal antibody and labelled with technetium-99m for targeted scintigraphy: 6-(4-isothiocyanatobenzyl)-5,7-dioxo-1,11-(carboxymethyl)-1,4,8,11-tetraazacyclotridecane.
Mishra AK; Panwar P; Hosono M; Chuttani K; Mishra P; Sharma RK; Chatal JF
J Drug Target; 2004; 12(9-10):559-67. PubMed ID: 15621681
[TBL] [Abstract][Full Text] [Related]
33. [Comparative studies of 111In-labeled monoclonal antibody using spacer-containing and non-spacer bifunctional chelates: (I). Conjugation, labeling, immunoreactivity and in vitro stability].
Sun B
Kaku Igaku; 1994 May; 31(5):459-71. PubMed ID: 8028218
[TBL] [Abstract][Full Text] [Related]
34. Stability of a metabolizable ester bond in radioimmunoconjugates.
Arano Y; Wakisaka K; Mukai T; Uezono T; Motonari H; Akizawa H; Kairiyama C; Ohmomo Y; Tanaka C; Ishiyama M; Sakahara H; Konishi J; Yokoyama A
Nucl Med Biol; 1996 Feb; 23(2):129-36. PubMed ID: 8868284
[TBL] [Abstract][Full Text] [Related]
35. Bifunctional chelator for facile preparation of neutral technetium complexes.
Baidoo KE; Lever SZ; Scheffel U
Bioconjug Chem; 1994; 5(2):114-8. PubMed ID: 8031873
[TBL] [Abstract][Full Text] [Related]
36. A convenient and flexible approach for introducing linkers on bifunctional chelating agents.
Studer M; Meares CF
Bioconjug Chem; 1992; 3(5):420-3. PubMed ID: 1420441
[TBL] [Abstract][Full Text] [Related]
37. Preparation and evaluation of new bifunctional chelating agents: a preliminary report.
Richard MD; Thakur ML; Stedman J; Damjanov A; Damjanov I
Int J Rad Appl Instrum B; 1990; 17(2):181-8. PubMed ID: 1971266
[TBL] [Abstract][Full Text] [Related]
38. Simplified method for conjugating macrocyclic bifunctional chelating agents to antibodies via 2-iminothiolane.
McCall MJ; Diril H; Meares CF
Bioconjug Chem; 1990; 1(3):222-6. PubMed ID: 2096914
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and chemical characterization of the novel agronomically relevant pentadentate chelate 2-(2-((2-hydroxybenzyl)amino)ethylamino)-2-(2-hydroxyphenyl)acetic acid (DCHA).
López-Rayo S; Hernández D; Lucena JJ; Escudero R; Gómez-Gallego M; Sierra MA
J Agric Food Chem; 2010 Jul; 58(13):7908-14. PubMed ID: 20527987
[TBL] [Abstract][Full Text] [Related]
40. In vivo and in vitro anti-leishmanial activities of 4-nitro-N-pyrimidin- and N-pyrazin-2-ylbenzenesulfonamides, and N2-(4-nitrophenyl)-N1-propylglycinamide.
Dea-Ayuela MA; Castillo E; Gonzalez-Alvarez M; Vega C; Rolón M; Bolás-Fernández F; Borrás J; González-Rosende ME
Bioorg Med Chem; 2009 Nov; 17(21):7449-56. PubMed ID: 19811921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
